Literature DB >> 10949920

Isozymic nature of spore coat-associated alanine racemase of Bacillus subtilis.

K Kanda-Nambu1, Y Yasuda, K Tochikubo.   

Abstract

Spore coat-associated alanine racemase of Bacillus subtilis, which converts L-alanine to D-alanine, that is, the germinant to the competitive inhibitor, to regulate spore germination for survival of the organism under unfavorable growth conditions, was examined. The dormant spores, L-alanine-initiated germination of which is inhibited by diphenylamine, were used to characterize the enzyme in the native form because of its unextractablility from dormant spores. The presence of isozymes, Enz-I and Enz-II with Km for L-alanine of about 20mM and 50mM and optimum activity at around 40 degrees C and 65 degrees C, respectively, was proposed. The enzymes were selectively used depending on the L-alanine concentration and the temperature. The pH profiles of the activity (optimun at pH 9.0) and the stability (stable between pH 6-11 at 60 degrees C) were similar, but Enz-II was more heat-stable than Enz-I and the denaturation curve demonstrated a two-domain structure for Enz-II. Sensitivity to D-penicillamine, hydroxylamine and HgCl2 was similar between Enz-I and Enz-II, while that to D-cycloserine, L- and D-aminoethylphosphonic acid, monoiodoacetate and N-ethylmaleimide was different; HgCl2 was the most effective inhibitor among these compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949920     DOI: 10.1007/s007260070076

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

1.  Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation.

Authors:  Indira T Kudva; Robert W Griffin; Jeonifer M Garren; Stephen B Calderwood; Manohar John
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Use of the alr gene as a food-grade selection marker in lactic acid bacteria.

Authors:  Peter A Bron; Marcos G Benchimol; Jolanda Lambert; Emmanuelle Palumbo; Marie Deghorain; Jean Delcour; Willem M De Vos; Michiel Kleerebezem; Pascal Hols
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

3.  Expression, purification, and characterization of alanine racemase from Pseudomonas putida YZ-26.

Authors:  Jun-Lin Liu; Xiao-Qin Liu; Ya-Wei Shi
Journal:  World J Microbiol Biotechnol       Date:  2011-06-21       Impact factor: 3.312

4.  The Bacillus subtilis germinant receptor GerA triggers premature germination in response to morphological defects during sporulation.

Authors:  Fernando H Ramírez-Guadiana; Alexander J Meeske; Xindan Wang; Christopher D A Rodrigues; David Z Rudner
Journal:  Mol Microbiol       Date:  2017-07-06       Impact factor: 3.501

5.  The spore-specific alanine racemase of Bacillus anthracis and its role in suppressing germination during spore development.

Authors:  Olga N Chesnokova; Sylvia A McPherson; Christopher T Steichen; Charles L Turnbough
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

6.  Identification of Bacillus anthracis spore component antigens conserved across diverse Bacillus cereus sensu lato strains.

Authors:  Sanghamitra Mukhopadhyay; Arya Akmal; Andrew C Stewart; Ru-Ching Hsia; Timothy D Read
Journal:  Mol Cell Proteomics       Date:  2009-02-09       Impact factor: 5.911

Review 7.  Proteomics reveals that proteins expressed during the early stage of Bacillus anthracis infection are potential targets for the development of vaccines and drugs.

Authors:  Chun-Ming Huang; Craig A Elmets; De-chu C Tang; Fuming Li; Nabiha Yusuf
Journal:  Genomics Proteomics Bioinformatics       Date:  2004-08       Impact factor: 7.691

8.  Characterization of Lactobacillus salivarius alanine racemase: short-chain carboxylate-activation and the role of A131.

Authors:  Jyumpei Kobayashi; Jotaro Yukimoto; Yasuhiro Shimizu; Taketo Ohmori; Hirokazu Suzuki; Katsumi Doi; Toshihisa Ohshima
Journal:  Springerplus       Date:  2015-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.